Migraine and cardiovascular disease in women and the role of aspirin: Subgroup analyses in the Women's Health Study

Cephalalgia

Volumn 31, Issue 10, 2011, Pages 1106-1115

  Kurth, Tobias ^a,b,c   Diener, Hans Christoph ^d   Buring, Julie E ^a  

^a Brigham and Womens's Hospital   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Aspirin; cardiovascular disease; migraine; randomized clinical trial

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MIGRAINE; MIGRAINE WITH AURA; RISK ASSESSMENT; SMOKING HABIT; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MIDDLE AGED; MIGRAINE WITH AURA; PRIMARY PREVENTION; RISK FACTORS;

EID: 79960722525     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411412628     Document Type: Article

References (46)

1. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA. 2006 ; 296: 283-291 (Pubitemid 44079312)
2. Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, et al. Migraine and cardiovascular disease: a population-based study. Neurology. 2010 ; 74: 628-635
3. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009 ; 339: b3914 - b3914
4. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004 ; 291: 427-434 (Pubitemid 38129746)
5. Scher AI, Gudmundsson LS, Sigurdsson S, Ghambaryan A, Aspelund T, Eiriksdottir G, et al. Migraine headache in middle age and late-life brain infarcts. JAMA. 2009 ; 301: 2563-2570
6. Kurth T, Mohamed S, Maillard P, Zhu YC, Chabriat H, Mazoyer B, et al. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ. 2011 ; 342: c7357 - c7357
7. MacClellan LR, Giles WH, Cole J, Wozniak MA, Stern B, Mtichell B, et al. Probable migraine with visual aura and risk of ischemic stroke: the Stroke Prevention in Young Women Study. Stroke. 2007 ; 38: 2438-2445 (Pubitemid 47329619)
8. Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ. 2008 ; 337: a636 - a636
9. Pezzini A, Grassi M, Del Zotto E, Giossi A, Monastero R, Dalla Volta G, et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke. 2007 ; 38: 3145-3151 (Pubitemid 350175728)
10. Schurks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677 C>T polymorphism, migraine, and cardiovascular disease. Neurology. 2008 ; 71: 505-513
11. Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology. 2007 ; 68: 1563-1570 (Pubitemid 46717979)
12. Lee ST, Chu K, Jung KH, Kim DH, Kim EH, Choe VN, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology. 2008 ; 70: 1510-1517 (Pubitemid 351589504)
13. Napoli R, Guardasole V, Zarra E, Matarazzo M, D'Anna C, Sacca F, et al. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology. 2009 ; 72: 2111-2114
14. D'Andrea G, Toldo M, Cananzi A, Ferro-Milone F. Study of platelet activation in migraine: control by low doses of aspirin. Stroke. 1984 ; 15: 271-275 (Pubitemid 14171259)
15. Tietjen GE, Al-Qasmi MM, Athanas K, Dafer RM, Khuder SA. Increased von Willebrand factor in migraine. Neurology. 2001 ; 57: 334-336 (Pubitemid 32667373)
16. Tietjen GE. Migraine as a systemic disorder. Neurology. 2007 ; 68: 1555-1556 (Pubitemid 46717977)
17. Nozari A, Dilekoz E, Sukhotinsky I, Stein T, Eikermann-Haerter K, Liu C, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Annals of Neurology. 2010 ; 67: 221-229
18. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB. Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology. 2009 ; 72: 1864-1871
19. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009 ; 373: 1849-1860
20. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 ; 231: 232-235
21. Buring JE, Peto R, Hennekens CH. Low-dose aspirin for migraine prophylaxis. JAMA. 1990 ; 264: 1711-1713 (Pubitemid 20324354)
22. Bensenor IM, Cook NR, Lee IM, Chown MJ, Hennekens CH, Buring JE. Low-dose aspirin for migraine prophylaxis in women. Cephalalgia. 2001 ; 21: 175-183 (Pubitemid 32589033)
23. Diener HC. Low-dose aspirin for migraine prophylaxis in women. Cephalalgia. 2001 ; 21: 167-168
24. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med. 2000 ; 9: 19-27 (Pubitemid 30148098)
25. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Eng J Med. 2005 ; 352: 1293-1304
26. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005 ; 294: 56-65 (Pubitemid 41002839)
27. Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005 ; 294: 47-55 (Pubitemid 41002838)
28. Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology. 2005 ; 64: 1020-1026 (Pubitemid 40388455)
29. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988 ; 8 (Suppl 7). 1-96
30. Schurks M, Buring JE, Kurth T. Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study. Cephalalgia. 2009 ; 29: 1086-1090
31. Olesen J, Steiner TJ. The international classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatr. 2004 ; 75: 808-811 (Pubitemid 38658498)
32. Atiya M, Kurth T, Berger K, Buring JE, Kase CS. Interobserver agreement in the classification of stroke in the Women's Health Study. Stroke. 2003 ; 34: 565-567 (Pubitemid 36206365)
33. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Ntl Cancer Inst. 1999 ; 91: 2102-2106 (Pubitemid 30019571)
34. Lampl C, Voelker M, Diener HC. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurology. 2007 ; 254: 705-712 (Pubitemid 47012463)
35. O'Neill BP, Mann JD. Aspirin prophylaxis in migraine. Lancet. 1978 ; 2: 1179-1181 (Pubitemid 9047369)
36. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology. 1999 ; 53: 537-542 (Pubitemid 29382048)
37. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001 ; 41: 646-657 (Pubitemid 32777747)
38. Hosman-Benjaminse SL, Bolhuis PA. Migraine and platelet aggregation in patients treated with low dose acetylsalicylic acid. Headache. 1986 ; 26: 282-284 (Pubitemid 17074274)
39. Kurth T, Glynn RJ, Walker AM, Chan KA, Buring JE, Hennekens CH, et al. Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation. 2003 ; 108: 1191-1195 (Pubitemid 37099986)
40. Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001 ; 345: 1809-1817
41. Ikonomidis I, Lekakis J, Vamvakou G, Andreotti F, Nihoyannopoulos P. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am Heart J. 2005 ; 149: 832-839 (Pubitemid 40718878)
42. Hennekens CH, Schneider WR, Hebert PR, Tantry US, Gurbel PA. Hypothesis formulation from subgroup analyses: nonadherence or nonsteroidal anti-inflammatory drug use explains the lack of clinical benefit of aspirin on first myocardial infarction attributed to 'aspirin resistance'. Am Heart J. 2010 ; 159: 744-748
43. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin 'resistance' and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ. 2008 ; 336: 195-198 (Pubitemid 351212675)
44. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study The World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ. 1999 ; 318: 13-18
45. Kurth T, Kase CS, Schurks M, Tzourio C, Buring JE. Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ. 2010 ; 341: c3659 - c3659
46. Rist PM, Buring JE, Kase CS, Schurks M, Kurth T. Migraine and functional outcome from ischemic cerebral events in women. Circulation. 2010 ; 122: 2551-2557